In conclusion, our findings indicate that GEM and DOC have different robust cellular effects in different NSCLC cell lines and provide a landscape of how currently used chemotherapeutics influence the expression of key lncRNAs in NSCLC—MALAT1, NEAT1, and HOTAIR. The gene discussed is MALAT1; the disease is non-small cell lung carcinoma.